Mycobacterium vaccae immunotherapy for treating tuberculosis
- 20 January 2003
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2003 (1), CD001166
- https://doi.org/10.1002/14651858.cd001166
Abstract
Some authorities have advocated Mycobacterium vaccae immunotherapy for treating tuberculosis and other infections caused by mycobacteria. To assess the effects of Mycobacterium vaccae as an adjunct to chemotherapy for treating tuberculosis. We searched the Cochrane Infectious Diseases Group trials register, the Cochrane Controlled Trials register, Medline, Embase and reference lists of articles. We also contacted organisations and individuals working in the field. Randomised and quasi-randomised trials using whole, killed Mycobacterium vaccae for patients with tuberculosis. One reviewer assessed trial quality and extracted data. Six trials met the inclusion criteria. There was no effect on mortality (three trials, OR 1.01, 95% CI 0.51 to 1.99). No consistent effect on sputum negativity or sputum culture was shown. Most immunotherapy recipients experienced local adverse reactions (two trials, OR 18.2, 95% CI 9 to 37), some of which progressed to ulceration and scarring. Immunotherapy with Mycobacterium vaccae does not appear to benefit patients with tuberculosis.Keywords
This publication has 29 references indexed in Scilit:
- Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trialThe Lancet, 2002
- Randomized Controlled Trial ofMycobacterium vaccaeImmunotherapy in Non–Human Immunodeficiency Virus–Infected Ugandan Adults with Newly Diagnosed Pulmonary TuberculosisThe Journal of Infectious Diseases, 2000
- Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trialThe Lancet, 1999
- ABC of allergies: Venom allergyBMJ, 1998
- Pathogenesis of Mycobacterial DiseasePublished by Springer Science and Business Media LLC ,1998
- Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed diseaseRespiratory Medicine, 1997
- Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary diseaseRespiratory Medicine, 1997
- Immunotherapy of Tuberculosis with Mycobacterium vaccae NCTC 11659Immunobiology, 1994
- An investigation of patients with pulmonary tuberculosis in Kuwait in preparation for studies of immunotherapy with Mycobacterium vaccaeTubercle, 1990
- Immunotherapy of Localized, Intermediate, and Diffuse Forms of American Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 1989